UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The contribution of inflammatory astrocytes to BBB impairments in a brain-chip model of Parkinson’s disease

Nature communications, 2023-06, Vol.14 (1), p.3651-3651, Article 3651

2023

Volltextzugriff (PDF)

Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (8), p.1170-1180

2018

Volltextzugriff (PDF)

Unexpected outcome of a sigmoid lesion believed to be malignant

Acta gastro-enterologica belgica, 2023-04, Vol.86 (2), p.383-384

2023

Volltextzugriff (PDF)

An underrecognized cause of hepatomegaly in uncontrolled type I diabetes

Acta gastro-enterologica belgica, 2023-07, Vol.86 (3), p.507-508

2023

Volltextzugriff (PDF)

CYP2D6 polymorphism may contribute to Trazodone-induced hepatotoxicity: a rare case of drug-drug-gene induced liver injury

Acta gastro-enterologica belgica, 2024-04, Vol.87 (2), p.332-335

2024

Volltextzugriff (PDF)

The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C‐infected patients treated with direct‐acting antivirals with and without pegylated interferon: A Belgian experience

Journal of viral hepatitis, 2017-11, Vol.24 (11), p.976-981

2017

Volltextzugriff (PDF)

Transjugular intrahepatic portosystemic shunt placement for symptomatic non- bleeding anorectal varices in nodular regenerative hyperplasia

Acta gastro-enterologica belgica, 2020-04, Vol.83 (2), p.331-333

2020

Volltextzugriff (PDF)

Final results of a phase II quality of life (QOL) randomized, cross-over (CO) study with gemcitabine (Gem) and nab-paclitaxel (n-P) in locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC): QOLINPAC

Annals of oncology, 2018-10, Vol.29, p.viii252-viii252

2018

Volltextzugriff (PDF)

Comorbidities and concomitant medications in patients with chronic hepatitis C virus infection receiving second-generation direct-acting antiviral regimens in Belgium: an observational study

Acta gastro-enterologica belgica, 2021-01, Vol.84 (1), p.33-41

2021

Volltextzugriff (PDF)

Gemcitabine with nab-paclitaxel in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC): A quality of life randomized cross-over study (QOLINPAC)

Annals of oncology, 2018-06, Vol.29, p.v101-v101

2018

Volltextzugriff (PDF)

Current practice in approaching controversial diagnostic and therapeutic topics in gastroenteropancreatic neuroendocrine neoplasm management. Belgian multidisciplinary expert discussion based on a modified Delphi method

Acta gastro-enterologica belgica, 2020-10, Vol.83 (4), p.643-653

2020

Volltextzugriff (PDF)

The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C infected patients treated with direct acting antivirals with and without pegylated interferon: a Belgian experience

Journal of hepatology, 2017, Vol.66 (1), p.S623-S624

2017

Volltextzugriff (PDF)

1609 Final results from PAVES, a phase 3, randomized, double-blind, placebo-controlled trial of pegfilgrastim in patients (pts) receiving first-line FOLFOX or FOLFIRI and bevacizumab for locally advanced or metastatic colorectal cancer (LA/mCRC) (NCT00911170)

European journal of cancer (1990), 2015-09, Vol.51, p.S241-S241

2015

Volltextzugriff (PDF)

Hepatorenaal syndroom na embolisatie van een splenorenale shunt

Tijdschrift voor geneeskunde, 2023-02

2023

Volltextzugriff (PDF)

Azathioprine induced serious portal hypertension: a case series of three IBD patients and review of the literature

Acta gastro-enterologica belgica, 2013-09, Vol.76 (3), p.342-346

2013

Volltextzugriff (PDF)

468P PANIB 20139173: Randomized, multicentre phase II trial comparing fluorouracil, leucovorin and oxaliplatin (FOLFOX) plus panitumumab versus FOLFOX plus bevacizumab in patients with previously untreated, RAS wild-type (WT) metastatic colorectal cancer (mCRC)

Annals of oncology, 2020-09, Vol.31, p.S440-S440

2020

Volltextzugriff (PDF)

PTU-039 Outcome of endoscopic mucosal resection of 424 large sessile colonic polyps (≥20 mm) over a 9 year period: a single centre experience and analysis of change with time

Gut, 2015-06, Vol.64 (Suppl 1), p.A75-A76

2015

Volltextzugriff (PDF)

PWE-049 Audit On Emr Of Large Colonic Polyps (size >20 Mm)

Gut, 2014-06, Vol.63 (Suppl 1), p.A144-A144

2014

Volltextzugriff (PDF)

PWE-049Audit On Emr Of Large Colonic Polyps (size >20 Mm)

Gut, 2014-06, Vol.63 (Suppl 1), p.A144-A144

2014

Volltextzugriff (PDF)

Conditional analyses of recurrence and progression in patients with TaG1 non–muscle-invasive bladder cancer

Urologic oncology, 2018-05, Vol.36 (5), p.238.e19-238.e27

2018

Volltextzugriff (PDF)

740PFinal results of a phase II quality of life (QOL) randomized, cross-over (CO) study with gemcitabine (Gem) and nab-paclitaxel (n-P) in locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC): QOLINPAC

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients

Journal of Crohn's and colitis, 2013-03, Vol.7 (2), p.154-160

2013

Volltextzugriff (PDF)

O-003Gemcitabine with nab-paclitaxel in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC): A quality of life randomized cross-over study (QOLINPAC)

Annals of oncology, 2018-06, Vol.29 (suppl_5)

2018

Volltextzugriff (PDF)

1 – 25 von 355

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(309)
Mit Volltextzugriff
(283)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

The contribution of inflammatory astrocytes to BBB impairments in a brain-chip model of Parkinson’s disease

Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes

Unexpected outcome of a sigmoid lesion believed to be malignant

An underrecognized cause of hepatomegaly in uncontrolled type I diabetes

CYP2D6 polymorphism may contribute to Trazodone-induced hepatotoxicity: a rare case of drug-drug-gene induced liver injury

The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C‐infected patients treated with direct‐acting antivirals with and without pegylated interferon: A Belgian experience

Transjugular intrahepatic portosystemic shunt placement for symptomatic non- bleeding anorectal varices in nodular regenerative hyperplasia

Final results of a phase II quality of life (QOL) randomized, cross-over (CO) study with gemcitabine (Gem) and nab-paclitaxel (n-P) in locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC): QOLINPAC

Comorbidities and concomitant medications in patients with chronic hepatitis C virus infection receiving second-generation direct-acting antiviral regimens in Belgium: an observational study

Gemcitabine with nab-paclitaxel in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC): A quality of life randomized cross-over study (QOLINPAC)

Current practice in approaching controversial diagnostic and therapeutic topics in gastroenteropancreatic neuroendocrine neoplasm management. Belgian multidisciplinary expert discussion based on a modified Delphi method

The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C infected patients treated with direct acting antivirals with and without pegylated interferon: a Belgian experience

1609 Final results from PAVES, a phase 3, randomized, double-blind, placebo-controlled trial of pegfilgrastim in patients (pts) receiving first-line FOLFOX or FOLFIRI and bevacizumab for locally advanced or metastatic colorectal cancer (LA/mCRC) (NCT00911170)

Hepatorenaal syndroom na embolisatie van een splenorenale shunt

Azathioprine induced serious portal hypertension: a case series of three IBD patients and review of the literature

Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma

468P PANIB 20139173: Randomized, multicentre phase II trial comparing fluorouracil, leucovorin and oxaliplatin (FOLFOX) plus panitumumab versus FOLFOX plus bevacizumab in patients with previously untreated, RAS wild-type (WT) metastatic colorectal cancer (mCRC)

Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial

PTU-039 Outcome of endoscopic mucosal resection of 424 large sessile colonic polyps (≥20 mm) over a 9 year period: a single centre experience and analysis of change with time

PWE-049 Audit On Emr Of Large Colonic Polyps (size >20 Mm)

PWE-049Audit On Emr Of Large Colonic Polyps (size >20 Mm)

Conditional analyses of recurrence and progression in patients with TaG1 non–muscle-invasive bladder cancer

740PFinal results of a phase II quality of life (QOL) randomized, cross-over (CO) study with gemcitabine (Gem) and nab-paclitaxel (n-P) in locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC): QOLINPAC

Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients

O-003Gemcitabine with nab-paclitaxel in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC): A quality of life randomized cross-over study (QOLINPAC)

Suchergebnisse filtern